Literature DB >> 28571223

Neonatal Hyperthyroidism with Fulminant Liver Failure: A Case Report.

Mohammed Hasosah1, Khalid Alsaleem2, Mansour Qurashi1, Abdullah Alzaben3.   

Abstract

Neonatal hyperthyroidism is a rare disease that is seen in infants born to mothers with Graves' disease. Hepatic manifestation of neonatal hyperthyroidism is extremely rare. We describe a neonate with fulminant liver failure secondary to neonatal hyperthyroidism caused by maternal Graves's disease. The baby was admitted with low birth weight and hepatosplenomegaly. At day 2 of life, the baby was irritable and he developed respiratory distress and fulminant hepatic failure which required mechanical ventilation. All investigations of obstructive, infectious and metabolic causes of hepatic failure were negative. His hepatic dysfunction improvement was correlated with initiation carbimazole as anti-thyroid medication. The conjugated hyperbilirubinemia, liver enzymes and International Normalised Ratio (INR) were gradually improved with normalization by eight weeks. This case has been reported to illustrate lessons learnt for early identification of neonate with hyperthyroidism as potential cause of cholestasis is important, because delayed treatment of hyperthyroidism might lead to irreversible consequences such as mental retardation or even death due to liver failure.

Entities:  

Keywords:  Cholestasis; Graves’ disease; Liver diseases

Year:  2017        PMID: 28571223      PMCID: PMC5449869          DOI: 10.7860/JCDR/2017/21503.9641

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil.

Authors:  C Y Hayashida; A J Duarte; A E Sato; E H Yamashiro-Kanashiro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

Review 2.  Maternally transferred thyroid disease in the infant: recognition and treatment.

Authors:  T P Foley
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

3.  Neonatal cholestasis caused by hyperthyroidism.

Authors:  Lindsey A Loomba-Albrecht; Andrew A Bremer; Allison Wong; Anthony F Philipps
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-03       Impact factor: 2.839

4.  Hyperthyroidism and hepatic dysfunction. A case series analysis.

Authors:  T L Fong; J G McHutchison; T B Reynolds
Journal:  J Clin Gastroenterol       Date:  1992-04       Impact factor: 3.062

5.  Thyroxine induced stress and its possible prevention by catechin.

Authors:  Amar K Chandra; Sabyasachi Sinha; Shyamosree Roy Choudhury
Journal:  Indian J Exp Biol       Date:  2010-06       Impact factor: 0.818

Review 6.  Clinical practice: neonatal cholestasis.

Authors:  Ruth De Bruyne; Stephanie Van Biervliet; Saskia Vande Velde; Myriam Van Winckel
Journal:  Eur J Pediatr       Date:  2011-01-20       Impact factor: 3.183

7.  An unusual cause of neonatal coagulopathy and liver disease.

Authors:  C Dryden; J H Simpson; L E Hunter; L Jackson
Journal:  J Perinatol       Date:  2007-05       Impact factor: 2.521

8.  Neonatal thyrotoxicosis and conjugated hyperbilirubinemia.

Authors:  R S Beroukhim; T D Moon; E I Felner
Journal:  J Matern Fetal Neonatal Med       Date:  2003-06

Review 9.  Hyperthyroidism in early infancy: pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism.

Authors:  M Polak
Journal:  Thyroid       Date:  1998-12       Impact factor: 6.568

Review 10.  Neonatal thyroid disorders.

Authors:  A L Ogilvy-Stuart
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-11       Impact factor: 5.747

  10 in total
  1 in total

1.  Risk factors for underlying comorbidities and complications in patients with hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Wei-Zhen Weng; Jun-Feng Chen; Xiao-Hua Peng; Miao Huang; Jing Zhang; Jing Xiong; Hui-Juan Cao; Bing-Liang Lin
Journal:  Epidemiol Infect       Date:  2022-07-05       Impact factor: 4.434

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.